Skip to content
Compound Analysis

Retatrutide 40mg (R&D Only) X 2

£180
IN STOCK

A 40mg Retatrutide formulation supplied in a pre-filled research device, provided exclusively for controlled laboratory R&D applications. Delivered in sealed format to support compound stability analysis, formulation studies, and delivery mechanism evaluation.

Package Contents

Retatrutide 40mg × 2 bundle includes:

2 pen 12 disposable needles instruction booklet

Safety Protocol: Produced for laboratory research only. Not for human or veterinary consumption.

Janoshik Third-Party Lab Analysis

Independently tested and verified by Janoshik Analytical.

Batch NumberAR1739JAT
Fill Volume2.4 mL
Purity99.269%
CompoundConcentrationVerified Content
Retatrutide18.22 mg/mL43.72 mg

Concentration is measured per ml; verified content reflects the total assayed mass across the stated fill volume.

SPECIFICATIONS · RETATRUTIDE 40MG

Every parameter, published.

Review the molecular identity, reported formulation details and laboratory documentation associated with this research material.

↗   Request spec sheet

Molecular

Sequence
39 amino acids
Molecular weight
4,731.27 Da
Formula
C221H342N54O72
Receptor
GLP-1 / GIP / GCG
Research class
Triple receptor agonist

Manufacturing

Reported batch
AR1739JAT
Reported fill
2.4 mL
KIT CONTENTS
2 pen, 12 disposable needles, instruction booklet
FORMAT
Multi-Dose Pen
Storage
Refrigerate at 2–8°C; protect from light; do not freeze

Verification

Reported purity
99.269%
Assayed content
43.72 mg
Identity / methods
Check source lab report
Batch traceability
AR1739JAT
Analytical record
Review test source ↗
Product questions

Common questions, answered straight.

Verification, formulation, documentation, storage and laboratory-use compliance.

What does HPLC verification mean for this research material?

High-performance liquid chromatography helps assess sample composition. It does not on its own establish suitability for human use. Check the analytical method, sample identifier and date on the relevant laboratory report.

Where can I find the kit contents and formulation details?

Product-specific kit contents are shown above. Refer to the supplied research information and batch documentation for further formulation details. A labelled quantity is not a recommendation for dosing.

How does batch traceability work?

Match the visible batch or lot identifier to the documentation for that exact research material. If a record is unavailable or does not match, request clarification from Alluvi.

What is the cold-chain shipping and storage process?

Consult the product-specific shipping and storage documentation. Laboratory staff should assess temperature records and package condition; do not assume all compounds require identical handling.

Is Retatrutide 40mg for human consumption?

No. This research material is supplied for laboratory R&D only and is not intended for human or veterinary consumption, injection or self-administration.

PRODUCT SNAPSHOT

Every batch, measured.

REPORTED PURITY 99.269% Shown in the existing Alluvi analytical record
LABORATORY DOCUMENTATION TEST SOURCE Review linked source and batch details
RESEARCH GRADE R&D ONLY Not approved for human or veterinary consumption

Research-use information

Retatrutide 40mg (R&D Only) X 2 is supplied for controlled laboratory research and analytical work. Review the product label, concentration, batch or lot details, storage guidance and available documentation before beginning any study. Researchers should define protocol, handling, measurement and record-keeping requirements before use. This material is not intended for human or veterinary use, diagnosis, treatment, prevention or consumption. For technical questions about documentation, batch information or wholesale research supply, contact Alluvi Healthcare before ordering.